2015 VFC GSK
Ended Awarded Last action
- Contract number
- HHSD200201562100I
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2015N16850 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $1,253,145,278.60
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC as the prime contractor. The contract, valued at up to $1.25 billion, is part of the Vaccines for Children (VFC) 2015 program and provides for the delivery of various vaccines and pharmaceutical products to support federal immunization and disease prevention initiatives.
Key products and services included under this multiple award IDV contract include seasonal influenza vaccines, pediatric and adult vaccines for routine immunization programs, and antiviral medications such as zanamivir. The contract also allows for the provision of vaccine storage and rotation services, as well as the supply of COVID-19 treatments and vaccine adjuvants. Performance will primarily occur at Glaxosmithkline's facilities in North Carolina, with no set-aside designations indicated. The 5-year contract period runs from April 2015 through March 2020, with specific quantities and delivery timelines determined through task orders placed by the CDC based on public health needs. This contract supports the CDC's efforts to ensure adequate stockpiles and distribution of critical vaccines and antivirals for federal, state, and local immunization programs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$1,538 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $122,950 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $127,247,541 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $175,185,053 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $67,642,785 | |
| Supplemental Agreement for work within scope | $28,594,309 | |
| Funding Only Action | $74,021,561 | |
| Other Administrative Action | $0 | |
| Original award | $123,501,853 |
Show all 19
Quick answers
Who was awarded contract HHSD200201562100I?
HHSD200201562100I was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2015.
How much is contract HHSD200201562100I worth?
HHSD200201562100I's own ceiling is $1,253,145,279.
Who can order from contract HHSD200201562100I?
HHSD200201562100I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSD200201562100I part of a contract vehicle?
Yes. HHSD200201562100I is part of Vaccines for Children 2015 (VFC 2015).
Was contract HHSD200201562100I competed?
The extent of competition for HHSD200201562100I was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV